retatrutide triple agonist glp-1 gip glucagon phase 3 2025 Dr Retatrutide, a TRIPLE agonist (GLP1,
Description
Tsai T, Hsu T, Chen C, Cheng J, Chiou M, Huang C, et al
Ann Hepatol
[DOI] [PubMed] [Google Scholar] 10.Seino Y., Fukushima M., Yabe D
Newer research also suggests gingerol can increase GLP-1 levels
BW, body weight
Frequency Once weekly Instructions Inject under the skin of your stomach, thigh, or upper arm Titration Start at 2.5mg, with increases every 4 weeks up to maximum 15mg Side Effects Common Side Effects Most side effects are mild and improve as your body adjusts to the medication
